217 related articles for article (PubMed ID: 6296652)
1. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
3. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
5. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
Woodcock EA; Johnston CI
Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
[TBL] [Abstract][Full Text] [Related]
6. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system.
Hui KK; Yu JL; Tse E; Borst S
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
Alexander RW; Cooper B; Handin RI
J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
[TBL] [Abstract][Full Text] [Related]
8. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
9. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
10. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
11. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
Mooney JJ; Horne WC; Handin RI; Schildkraut JJ; Alexander RW
Mol Pharmacol; 1982 May; 21(3):600-8. PubMed ID: 6287197
[No Abstract] [Full Text] [Related]
12. Interactions of agonists with platelet alpha 2-adrenergic receptors.
Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
14. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
Snavely MD; Insel PA
Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
[TBL] [Abstract][Full Text] [Related]
15. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
16. Clonidine and para-aminoclonidine, partial agonists for the alpha2-adrenergic receptor on intact human blood platelets.
Stump DC; Macfarlane DE
J Lab Clin Med; 1983 Nov; 102(5):779-87. PubMed ID: 6138385
[TBL] [Abstract][Full Text] [Related]
17. Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase.
Slotkin TA; McCook EC; Nemeroff CB; Seidler FJ
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):259-71. PubMed ID: 1658886
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung.
Latifpour J; Jones SB; Bylund DB
J Pharmacol Exp Ther; 1982 Dec; 223(3):606-11. PubMed ID: 6292392
[TBL] [Abstract][Full Text] [Related]
19. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
Valet P; Senard JM; Devedjian JC; Planat V; Salomon R; Voisin T; Drean G; Couvineau A; Daviaud D; Denis C
J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045
[TBL] [Abstract][Full Text] [Related]
20. Interaction of verapamil with human platelet alpha-adrenergic receptors.
Barnathan ES; Addonizio VP; Shattil SJ
Am J Physiol; 1982 Jan; 242(1):H19-23. PubMed ID: 6277203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
